Cizzle Bio, Inc., a Texas-based biotechnology company advancing biomarker blood tests for early detection of lung and gastric cancers, today announced the laboratory validation of its proprietary ...
Researchers have developed a highly sensitive light-based sensor that can detect extremely low concentrations of cancer biomarkers in the blood. The new technology could one day make it possible to ...
Cancer Institute today announced that its Biomarker Moonshot Cancer Research Program has surpassed 11,000 enrolled patients, marking five years of progress toward transforming cancer detection, ...
Colorectal cancer (CRC) is the second-leading cause of cancer-related deaths in Europe and the U.S.—yet when detected early, the 5-year survival rate jumps to 91%. While colonoscopy remains the gold ...
A pioneering blood-based cancer testing platform developed through Malta’s M3Profiler project can detect tumour diversity and ...
Adding aminopeptidase N and polymeric immunoglobin receptor to a plasma biomarker panel of carbohydrate antigen 19-9 (CA19-9) and thrombospondin 2 (THBS2) enhanced the detection of early-stage ...
A sensor that requires no nanoscale patterning detects single molecules of a breast cancer protein at concentrations 250 times lower than previous devices of its type. (Nanowerk Spotlight) A single ...
The prospect of diagnosing cancer through painless methods—such as a simple AI-assisted blood or urine test that detects tiny particles known as exosomes—is becoming increasingly realistic. Scientists ...
This study introduces a novel signal amplification method induced by aggregation, which achieves specific recognition and sensitive detection of two cancer biomarkers through the rational design of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results